Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Home
Profiles
Research units
Research output
Equipment
Search by expertise, name or affiliation
Rituximab
Anupama Borker
*
, Narendra Choudhary
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
31
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rituximab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
toxicity
100%
apoptosis
66%
lymphomas
66%
children
33%
diseases
33%
mice
33%
adults
33%
therapy
33%
humans
33%
surfaces
33%
organs
33%
antigens
33%
antibodies
33%
solids
33%
lymphocytes
33%
reactivation
33%
arthritis
33%
anemias
33%
monoclonal antibodies
33%
infusion
33%
leukemia
33%
purpura
33%
refractories
33%
complement
33%
lupus
33%
hemophilia
33%
Medicine and Dentistry
Rituximab
100%
B Cell
50%
CD20
50%
Programmed Cell Death
25%
Virus Infection
25%
Non-Hodgkin Lymphoma
25%
Infusion
25%
Salvage Therapy
25%
Bacterial Infection
25%
Rheumatoid Arthritis
25%
B-Cell Lymphoma
25%
Nephrotic Syndrome
25%
Idiopathic Thrombocytopenic Purpura
25%
Complement Dependent Cytotoxicity
25%
Evans Syndrome
25%
Human Monoclonal Antibody
25%
CD20 Antigen
25%
Cell Mediated Cytotoxicity
25%
B Lymphocyte
25%
Solid Organ Transplantation
25%
Acute Graft Rejection
25%
Post-Transplantation Lymphoproliferative Disease
25%
Chronic Graft Rejection
25%
Haemophilia A
25%
Cell Death
25%
Leukemia
25%
Systemic Lupus Erythematosus
25%
Systemic Vasculitis
25%
Opsoclonus Myoclonus Syndrome
25%
Inflammatory Arthritis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Rituximab
100%
Cytotoxicity
50%
Leukemia
25%
B Cell Lymphoma
25%
Systemic Vasculitis
25%
Virus Infection
25%
Nonhodgkin Lymphoma
25%
Bacterial Infection
25%
Rheumatoid Arthritis
25%
Autoimmune Hemolytic Anemia
25%
Human Monoclonal Antibody
25%
Chronic Graft Rejection
25%
Acute Graft Rejection
25%
CD20 Antigen
25%
Lymphoproliferative Disease
25%
Nephrotic Syndrome
25%
Idiopathic Thrombocytopenic Purpura
25%
Systemic Lupus Erythematosus
25%
Opsoclonus Myoclonus Syndrome
25%
Haemophilia A
25%
Inflammatory Arthritis
25%